State Of Wyoming Rhythm Pharmaceuticals, Inc. Transaction History

State Of Wyoming

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$16.88 - $34.24 $18,601 - $37,732	-1,102 Reduced 49.46%	1,126 $20,000
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $49,483 - $67,397	2,228 New	2,228 $64,000
Q2 2022 Aug 15, 2022	SELL	$3.12 - $12.25 $776 - $3,050	-249 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$6.13 - $12.24 $251 - $501	41 Added 19.71%	249 $3,000
Q4 2021 Feb 11, 2022	SELL	$8.62 - $13.9 $94 - $152	-11 Reduced 5.02%	208 $2,000
Q3 2021 Feb 11, 2022	SELL	$11.68 - $20.72 $852 - $1,512	-73 Reduced 25.0%	219 $3,000
Q2 2021 Feb 11, 2022	BUY	$18.52 - $22.55 $3,722 - $4,532	201 Added 220.88%	292 $6,000
Q1 2021 Feb 08, 2022	BUY	$20.25 - $39.49 $1,842 - $3,593	91 New	91 $2,000

191

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.